Viatris, Inc. (VTRS)
20.84
+0.17
(+0.82%)
USD |
NASDAQ |
Nov 13, 16:00
20.75
-0.09
(-0.43%)
After-Hours: 19:59
Viatris Price to Book Value : 1.746 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.732 |
| November 11, 2026 | 1.764 |
| November 10, 2026 | 1.747 |
| November 09, 2026 | 1.716 |
| November 06, 2026 | 1.668 |
| November 05, 2026 | 1.589 |
| November 04, 2026 | 1.610 |
| November 03, 2026 | 1.585 |
| November 02, 2026 | 1.564 |
| October 30, 2026 | 1.595 |
| October 29, 2026 | 1.608 |
| October 28, 2026 | 1.572 |
| October 27, 2026 | 1.568 |
| October 26, 2026 | 1.532 |
| October 23, 2026 | 1.508 |
| October 22, 2026 | 1.548 |
| October 21, 2026 | 1.546 |
| October 20, 2026 | 1.562 |
| October 19, 2026 | 1.530 |
| October 16, 2026 | 1.563 |
| October 15, 2026 | 1.526 |
| October 14, 2026 | 1.461 |
| October 13, 2026 | 1.445 |
| October 12, 2026 | 1.469 |
| October 09, 2026 | 1.478 |
| Date | Value |
|---|---|
| October 08, 2026 | 1.461 |
| October 07, 2026 | 1.465 |
| October 06, 2026 | 1.469 |
| October 05, 2026 | 1.476 |
| October 02, 2026 | 1.474 |
| October 01, 2026 | 1.463 |
| September 30, 2026 | 1.484 |
| September 29, 2026 | 1.468 |
| September 28, 2026 | 1.480 |
| September 25, 2026 | 1.444 |
| September 24, 2026 | 1.411 |
| September 23, 2026 | 1.387 |
| September 22, 2026 | 1.392 |
| September 21, 2026 | 1.385 |
| September 18, 2026 | 1.373 |
| September 17, 2026 | 1.388 |
| September 16, 2026 | 1.379 |
| September 15, 2026 | 1.349 |
| September 14, 2026 | 1.350 |
| September 11, 2026 | 1.338 |
| September 10, 2026 | 1.327 |
| September 09, 2026 | 1.337 |
| September 08, 2026 | 1.346 |
| September 04, 2026 | 1.368 |
| September 03, 2026 | 1.372 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Pacira Biosciences, Inc. | 2.042 |
| Pfizer Inc. | 1.851 |
| Eli Lilly & Co. | 33.76 |
| Merck & Co., Inc. | 8.118 |
| Amphastar Pharmaceuticals, Inc. | 1.538 |
Price to Book Value Related Metrics
| PS Ratio | 1.640 |
| Price to Free Cash Flow | 12.26 |
| Price | 20.84 |
| Earnings Yield | -2.54% |
| Market Cap | 23.89B |
| Operating PE Ratio | 15.26 |
| Normalized PE Ratio | 44.48 |